{"nct_id":"NCT00660920","title":"Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies","status":"COMPLETED","status_verified_date":"2018-02","start_date":"2008-06","start_date_type":"ACTUAL","primary_completion_date":"2016-05","primary_completion_date_type":"ACTUAL","completion_date":"2016-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TAK"]}